Paul R Edick Insider Trading $XERS XERIS PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Paul R Edick.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Paul R Edick. Paul R Edick is Director in PDL BIOPHARMA, INC. ($PDLI) and Director in NEWLINK GENETICS CORP ($NLNK) and See Remarks in XERIS PHARMACEUTICALS INC ($XERS) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in Milestone Pharmaceuticals Inc. ($MIST) and Director in Neos Therapeutics, Inc. ($NEOS) and Director in Iterum Therapeutics plc ($ITRM).

Paul R Edick in XERIS PHARMACEUTICALS INC

Trading Symbol: XERS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul R Edick: See Remarks
Holdings: 636,134 shares
Latest Transaction: Feb 01 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Paul R Edick in XERIS PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ITRM, NLNK, MIST, NEOS, PDLI, SCMP, XERS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 01 2021XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksOption ExerciseA5.08400,0002,032,000400,000
Feb 01 2021XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksGrantA0.00225,0000636,134411.1 K to 636.1 K (+54.73 %)
Dec 10 2020XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksBuyP4.0610,00040,551411,134401.1 K to 411.1 K (+2.49 %)
Dec 10 2020XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksBuyP4.0610,00040,551411,134401.1 K to 411.1 K (+2.49 %)
May 11 2020XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksBuyP3.0033,00099,000401,134368.1 K to 401.1 K (+8.96 %)
Mar 02 2020XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksGrantA0.00185,0000368,134183.1 K to 368.1 K (+101.02 %)
Mar 02 2020XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksGrantA0.00185,0000368,134183.1 K to 368.1 K (+101.02 %)
Feb 18 2020XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksBuyP4.1520,00083,000183,134163.1 K to 183.1 K (+12.26 %)
Feb 04 2020XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksPayment of ExerciseF6.379,80162,432163,134172.9 K to 163.1 K (-5.67 %)
Nov 27 2019XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksBuyP8.5517,935153,283172,935155 K to 172.9 K (+11.57 %)
Nov 27 2019XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksBuyP8.5517,935153,283172,935155 K to 172.9 K (+11.57 %)
Mar 12 2019XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksBuyP9.1230,000273,585155,000125 K to 155 K (+24.00 %)
Feb 01 2019XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksOption ExerciseA13.88200,0002,776,000200,000
Feb 01 2019XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksGrantA0.00125,0000125,0000 to 125 K
Jun 27 2018XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksOption ExerciseC0.0023,92200
Jun 27 2018XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksOption ExerciseC0.0023,92200
Jun 27 2018XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksBuyC0.0013,430013,4300 to 13.4 K
Jun 27 2018XERSXERIS PHARMACEUTIC ...Edick Paul RSee RemarksBuyC0.0013,430013,4300 to 13.4 K

Page:   1